60 Degrees Pharmaceuticals, Inc. stock is down -9.11% since 30 days ago. The next earnings date is Feb 3, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 December’s closed higher than November.
We are a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. Our principal executive offices are located at 1025 Connecticut Avenue NW Suite 1000, Washington, D.C.